(FDA Approved De Novo) Validating Impact on Childhood Subclinical Anxiety & Depression
Read More(FDA Approved De Novo) Validating Impact on Childhood Subclinical Anxiety & Depression
Read MoreExplore Dr. Mooves A&D’s exciting new features, designed to enhance cognitive skill-building and reward children’s engagement.
Read MoreNew field study launched by Dr. Mooves A&D to measure the app’s impact on childhood subclinical anxiety, depression, and emotional resilience.
Read MoreDr. Mooves A&D secures two groundbreaking patents, advancing innovative digital tools for children’s cognitive development and mental health.
Read MoreDr. Mooves A&D partners with HITLab to expand digital solutions that empower children to manage anxiety and depression.
Read More